# Peptilogics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/peptilogics

- Industry: Biotechnology
- Headquarters: Pittsburgh, US
- Website: www.peptilogics.com
- Total disclosed funding: $119M
- Latest round: Series B (Oct 16, 2025)
- Investors on record: 7

## About

Founded in 2013 and based in Pittsburgh, US, Peptilogics, Inc. is a clinical-stage biotechnology company that develops engineered peptide therapeutics to treat life-threatening infections, including prosthetic joint and cystic fibrosis-related lung infections, using a proprietary AI-driven discovery platform.

## Funding rounds

- Series B, Oct 16, 2025, $78M — Founders Fund, Beyond Ventures, Presight Capital, Narya, AMR Action Fund, Thiel Bio
- Series B, Dec 21, 2020, $35M — Founders Fund, Presight Capital
- Series A, Sep 29, 2017, $5.5M — BlueTree Venture Fund

## Investors

- BlueTree Venture Fund (https://capitalatlas.ai/funds/bluetree-venture-fund) — Series A
- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Series B
- Presight Capital — Series B
- Beyond Ventures — Series B
- Narya (https://capitalatlas.ai/funds/narya) — Series B
- AMR Action Fund (https://capitalatlas.ai/funds/amr-action-fund) — Series B
- Thiel Bio (https://capitalatlas.ai/funds/thiel-bio) — Series B